Edwards’ CEO Mussallem exercises stock options
Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem will this month begin exercising stock options that were nearing expiration through a pre-arranged stock trading plan under SEC rule 10b5-1.
The plan allows Mussallem to exercise and sell up to 35,000 shares per month with the intent of spreading sales smoothly over an extended period of time. Under Edwards policy, Mussallem must hold EW shares worth at least 6 times his base salary and at the conclusion of his planned sell-off he will still hold shares "well in excess" of that guideline, according to a press release.
EW shares were up 0.6% to $85.49 as of about 4:15 p.m. today. Read more
SRS Medical promotes Lee Brody to the corner office
Billerica, Mass.-based SRS Medical named Lee Brody, former company COO, to the corner office. Brody plans to focus on growing the company’s non-invasive CT3000 pressure-flow system, according to a statement. Read more
Advanced Cardiac Therapeutics shuffles the deck, builds its hand to support commercialization
Advanced Cardiac Therapeutics announced the appointment of Bill Olson as president & CEO as the company aims to build support behind commercialization and clinical efforts for its Tempasure cardiac ablation catheter.
The company also added ORSCO Life Sciences founder Oern Stuge to its board of directors and named Miriam Taimisto its VP of research & development. Read more
CardioKinetix names Maria Sainz president & CEO
Menlo Park, Calif.-based heart failure treatment maker CardioKinetix named Maria Sainz its new president & CEO. With more than 20 years in medical devices, Sainz was most recently general manager for Stryker‘s (NYSE:SYK) neurovascular division. Read more
Zeltiq interim president & CEO Mark Foley to receive $50k per month
Zeltiq (NSDQ:ZLTQ) named Mark Foley interim president & CEO following the resignation of Gordie Nye, who stepped down for personal reasons mid-April. Foley will receive $50,000 monthly during his stint as interim company head in addition to stock options, according to SEC filings. Read more